Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
about
Structure of recombinantLeishmania donovanipteridine reductase reveals a disordered active siteSecondary Metabolites in Ramalina terebrata Detected by UHPLC/ESI/MS/MS and Identification of Parietin as Tau Protein InhibitorIs It Reliable to Use Common Molecular Docking Methods for Comparing the Binding Affinities of Enantiomer Pairs for Their Protein Target?In silico screening, structure-activity relationship, and biologic evaluation of selective pteridine reductase inhibitors targeting visceral leishmaniasis.Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubesGreen Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia prostrata Extract Shows Shift from Apoptosis to G0/G1 Arrest followed by Necrotic Cell Death in Leishmania donovaniA member of the Ras oncogene family, RAP1A, mediates antileishmanial activity of monastrolAn alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.Genomic organization of leishmania species.Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.Discovery of triazine mimetics as potent antileishmanial agents.Chalcone Derivatives: Promising Starting Points for Drug Design.Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.Exploring the inhibitory activity of Withaferin-A against Pteridine reductase-1 of L. donovani.Leishmania donovani pteridine reductase 1: comparative protein modeling and protein-ligand interaction studies of the leishmanicidal constituents isolated from the fruits of Piper longum.Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
P2860
Q27666482-ABD7D512-CE0F-4B80-ABB0-EB344C995519Q28828799-29EFD24D-8325-4594-94FF-26B66D3FCB13Q28833848-155CBBA7-C140-444C-90B4-BFF2EEF5FFBDQ34528982-0DC6069F-FF9F-468F-BA84-F5BC522F967BQ35838239-A4108532-30EF-4025-8245-CF657D89FF56Q35859834-AAF73A45-625C-43B4-A61C-F78AA107BE0DQ36762981-7FC655C3-7089-4BC2-9F1A-6FA3E4DE41C8Q37069597-62D8F2A7-F824-4393-8907-4BC1BEE5488CQ37985972-B3A62F47-7956-4EF3-8199-E0BBFB67A3C2Q38758771-9F2910AD-E926-4AE7-8B3D-9BF9C09883ECQ38940416-1CFB37E4-0D84-48B6-9036-243897D4B8C6Q39027317-09501426-150C-43D5-88F2-1F7588624ED8Q39203200-3B161806-F464-4DBD-AC18-5BF8856E71AAQ40982074-EAFA348E-6382-4652-8CEF-1A7F0BEA9C8EQ46572071-7C1B86B3-393D-4589-9B63-CDE88FF6E178Q51534884-31E648F8-D6D9-411A-838F-5FDA64C82C8B
P2860
Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Molecular docking, structure-a ...... solate of Leishmania donovani.
@en
Molecular docking, structure-a ...... solate of Leishmania donovani.
@nl
type
label
Molecular docking, structure-a ...... solate of Leishmania donovani.
@en
Molecular docking, structure-a ...... solate of Leishmania donovani.
@nl
prefLabel
Molecular docking, structure-a ...... solate of Leishmania donovani.
@en
Molecular docking, structure-a ...... solate of Leishmania donovani.
@nl
P2860
P356
P1476
Molecular docking, structure-a ...... solate of Leishmania donovani.
@en
P2093
Jaspreet Kaur
Neeloo Singh
P2860
P304
P356
10.1093/JAC/DKQ189
P407
P50
P577
2010-06-02T00:00:00Z